3-(2-Amino-1,3-benzoxazol-5-yl)-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine(CAS: 1224844-38-5)

This compound falls under the purview of the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) for classification of health, environmental, and physical hazards. It is also subject to the European Union’s REACH regulations for registration, evaluation, authorization, and restriction of chemicals. For FDA and EPA requirements, it must meet stringent standards for safety, purity, and labeling. Companies handling this compound must ensure compliance with local and international regulations.

While 3-(2-Amino-1,3-benzoxazol-5-yl)-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine is a unique compound, alternatives include structurally similar isomers and analogs. Common substitutes in synthesis include 3-(1H-pyrazolo[3,4-d]pyrimidin-4-yl)-1-isopropyl-1,3-benzoxazol-2(3H)-amine and related derivatives. These alternatives can provide similar functionalities while potentially reducing synthesis complexity or environmental impact.

The market for this compound is currently driven by its potential applications in pharmaceuticals, particularly in the development of new drugs targeting specific diseases. Research trends are focusing on its bioavailability, pharmacokinetics, and its role in therapeutic areas such as oncology and neurology. Additionally, there is growing interest in its synthesis and purification methods to enhance its safety and efficacy.

Waste containing this compound should be collected in appropriate containers and stored under secure and controlled conditions to prevent environmental contamination. For disposal, it is recommended to use professional waste disposal services that can handle hazardous chemicals. Incineration is a common method, but it must be conducted in facilities equipped to manage the specific hazards of this compound. Environmental precautions include proper ventilation and personal protective equipment to safeguard against exposure.